Sanofi filed a complaint that alleged Seikagaku-developed and Zimmer-distributed Gel-One product infringed its patent for treating knee arthritis. A federal jury ruled last month that the patent includes administration through a single injection rather than multiple injections. The patent was also ruled invalid because it included “obvious variations of earlier work.”
More Articles on Orthopedic Devices:
14 Orthopedic & Spine Device Company Financial Reports
Smith & Nephew Looks for Merger or Acquisition Deal
Indian Market for Orthopedic Soft Tissue and Sports Medicine Devices Reached $17M in 2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
